article thumbnail

AstraZeneca Strengthens Canadian Life Sciences Footprint with $570M Investment

XTalks

The expansion will also contribute to building the province of Ontarios position as a global hub for life sciences and biotechnology. According to Invest Ontario, Ontario has the largest life sciences ecosystem in Canada, contributing to nearly 60% of the life science sectors national revenue.

article thumbnail

Cloudbyz Recognized in Everest Group’s 2024 PEAK Matrix® for Life Sciences CTMS Solution

Cloudbyz

We are deeply honored to be recognized in Everest Group’s PEAK Matrix® for Life Sciences CTMS solutions,” said Dinesh Kashyap, CEO and Founder of Cloudbyz. Our mission is to enable faster, more efficient trials, ultimately supporting the delivery of life-saving therapies.”

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Caris Life Sciences IPO Raises $494M to Advance AI-Driven Molecular Profiling and Oncology R&D

XTalks

Caris Life Sciences has officially stepped onto the public stage with its initial public offering (IPO), pricing 23,529,412 shares of its common stock at $21.00 The IPO, which launched on June 18, 2025, on the Nasdaq Global Select Market under the ticker “CAI,” raised approximately $494 million before expenses.

article thumbnail

Apiary invests in life sciences marketing specialist performance-io

Pharma Times

Private equity firm Apiary Capital backs rapid growth of performance-i

article thumbnail

White Paper - A Roadmap to AI Data Readiness in R&D Labs

Astrix brings its in-depth knowledge on how Life Science companies should prepare to deploy and leverage the power of AI/ML in a way that achieves both business and technical Download this comprehensive guide to AI and ML in the R&D Laboratory Setting.

article thumbnail

STAT+: At Aspen Ideas, a life science VC sees cause for long-term optimism despite a rocky market

STAT News

ASPEN, Colo. — When Jessica Owens was toiling away in graduate school, she didn’t know what a venture capitalist was, much less that she’d one day launch her own firm and raise its inaugural $45 million fund. program before she ditched the lab to explore the world of finance.

article thumbnail

How AI and machine learning are transforming drug discovery

Pharmaceutical Technology

Free Whitepaper How value-based care is reshaping the life sciences This free white paper examines the benefits of value-based care (VBC) and how this translates into the wider life-sciences landscape. link] [viii] GlobalData: February 20, 2025 Analyst Briefing.

Drugs 216